Gerald Quirk
Conseiller Juridique Général chez SYROS PHARMACEUTICALS, INC.
Fortune : 202 761 $ au 30/04/2024
Profil
Gerald E.
Quirk is currently the Chief Legal Officer at Syros Pharmaceuticals, Inc. He previously worked as Co-Chairman-Life Sciences Group at Choate, Hall & Stewart LLP, Managing Corporate Counsel at Genzyme Corp., Secretary, VP-Corporate Affairs & General Counsel at Infinity Pharmaceuticals, Inc., and Executive VP-Business Operations & General Counsel at Tokai Pharmaceuticals, Inc. He also worked as an Associate-Business Law Department at Palmer & Dodge LLP.
Quirk received his undergraduate degree from Swarthmore College and his graduate degrees from Harvard University and Northeastern University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/03/2024 | 39 757 ( 0,15% ) | 202 761 $ | 30/04/2024 |
Postes actifs de Gerald Quirk
| Sociétés | Poste | Début |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Anciens postes connus de Gerald Quirk
| Sociétés | Poste | Fin |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Directeur Administratif | 01/03/2022 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Conseiller Juridique Général | 31/08/2016 |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/05/2015 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 01/08/2012 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/09/2006 |
Formation de Gerald Quirk
| Northeastern University | Graduate Degree |
| Harvard University | Graduate Degree |
| Swarthmore College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Palmer & Dodge LLP | Commercial Services |
Choate, Hall & Stewart LLP
Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Commercial Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |